David Henderson is the founder of DayTwo. DayTwo has raised $85M in total funding. Latest round: Growth. Backed by Cathay Innovation, aMoon.
David Henderson was appointed CEO of DayTwo, a company specializing in precision nutrition using proprietary microbiome science to offer solutions for metabolic diseases like diabetes, prediabetes, and obesity. DayTwo raised $37 million in new funding, bringing its total to $85 million. Henderson was previously a founding executive member of Oscar Health.
Full founder directory · Investor directory · Company funding database · Fundraising library